Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Prostate Cancer (Diagnosis)”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07644598
What this trial is testing

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Georgetown University 58
Not applicableUnknownNCT05584787
What this trial is testing

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

Who this might be right for
Prostate Cancer
San Carlo di Nancy Hospital 20
Not applicableActive Not RecruitingNCT05345444
What this trial is testing

Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 48
Testing effectiveness (Phase 2)UnknownNCT03845751
What this trial is testing

EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.

Who this might be right for
Prostate CancerAndrogen Deprivation Therapy
Institut Mutualiste Montsouris 20
Not applicableStudy completedNCT01423474
What this trial is testing

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

Who this might be right for
Prostatic Neoplasms
CancerCare Manitoba 152
Testing effectiveness (Phase 2)Looking for participantsNCT07332000
What this trial is testing

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Who this might be right for
Prostate Cancer Patients Treated by RadiotherapyProstate Cancer (Adenocarcinoma)
Candel Therapeutics, Inc. 45
Large-scale testing (Phase 3)Looking for participantsNCT01492972
What this trial is testing

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Proton Collaborative Group 192
Very early researchNot Yet RecruitingNCT07727473
What this trial is testing

Preoperative Semaglutide Prior to Radical Prostatectomy

Who this might be right for
Prostate Cancer
Banner Health 20
Not applicableStudy completedNCT01657942
What this trial is testing

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Who this might be right for
Localized Intermediate Risk Prostate Lesions
InSightec 101
Testing effectiveness (Phase 2)UnknownNCT02077335
What this trial is testing

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
CSSS de Gatineau 50
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Large-scale testing (Phase 3)Study completedNCT00005044
What this trial is testing

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,579
Large-scale testing (Phase 3)Study completedNCT00833248
What this trial is testing

Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 246
Testing effectiveness (Phase 2)Study completedNCT02397408
What this trial is testing

11C- and 18F-Choline PET/MR Imaging for Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 18
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Not applicableStudy completedNCT00688532
What this trial is testing

Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not

Who this might be right for
Prostate Cancer
AstraZeneca 5,103
Large-scale testing (Phase 3)Ended earlyNCT03921996
What this trial is testing

Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Swiss Cancer Institute 57
Not applicableActive Not RecruitingNCT01617161
What this trial is testing

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Massachusetts General Hospital 454
Not applicableStudy completedNCT00977860
What this trial is testing

Hypofractionated SBRT For Prostate Cancer

Who this might be right for
Prostate Cancer
Adam Olson 163
Testing effectiveness (Phase 2)UnknownNCT01890096
What this trial is testing

A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

Who this might be right for
Carcinoma of the Prostate
Sunnybrook Health Sciences Centre 174
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation